Nipro Corporation competitorsClear all
Nipro Corporation's top competitors include West Pharmaceutical Services, Eisai, Kuraray, Takeda Pharmaceutical, Astellas Pharma and Nikkiso.
 Nipro Corporation Nipro Corporation (ニプロ株式会社) is a company that develops medical devices, pharmaceuticals, and pharma packaging. |  West Pharmaceutical Services West Pharmaceutical Services is a company that manufactures and sells packaging components and delivery systems for injectable drugs and healthcare products internationally. |  Eisai Eisai is a research-based human health care company that discovers, develops, packages, and markets pharmaceutical products. |  Kuraray Kuraray is a company that manufactures chemicals, synthetic and chemical fibers, and other materials. |  Astellas Pharma Astellas Pharma (アステラス製薬株式会社) is a pharmaceutical company focused on the development of drugs and medical solutions. |  Nikkiso Nikkiso is a company that engages in industrial, precision equipment, aerospace, and medical businesses. | ||
Founding Date | Founding Date 1954 | Founding Date 1923 | Founding Date 1941 | Founding Date 1926 | Founding Date 1781 | Founding Date 1923 | Founding Date 1953 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | |||||||
Locations | Locations Osaka, JP HQ Bunkyo City, JP Kusatsu, JP Kusatsu, JP Ohdate, JP | Locations Tokyo, JP HQ Macquarie Park, AU Wien, AT Vilvoorde, BE São Paulo, BR Markham, CA Beijing, CN see more | Locations Shibuya, JP HQ Shanghai, CN Shanghai, CN Shanghai, CN Wei Hai Shi, CN Hamburg, DE Langenhagen, DE see more | ||||
Employees | Employees 35,251 | Employees 10,0659% increase | Employees 11,3221% increase | Employees 11,11522% increase | Employees 47,0991% decrease | Employees 15,4553% decrease | Employees 8,7894% increase |
Valuation ($) | Valuation ($) 1.3 b | Valuation ($) 22.3 b | Valuation ($) 12.2 b | Valuation ($) 2.9 b | Valuation ($) 45.9 b | Valuation ($) 28.5 b | Valuation ($) 449.3 m |
Twitter followers | Twitter followers N/A | Twitter followers 2.5 k | Twitter followers 6 k | Twitter followers 868 | Twitter followers N/A | Twitter followers 50.4 k | Twitter followers 30 |
Number of tweets (last 30 days) | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 61 | Number of tweets (last 30 days) 36 | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) N/A | Number of tweets (last 30 days) 25 | Number of tweets (last 30 days) N/A |
Average likes per tweet (last 30 days) | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 0.5 | Average likes per tweet (last 30 days) 5.5 | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) N/A | Average likes per tweet (last 30 days) 5.8 | Average likes per tweet (last 30 days) N/A |
Percentage of tweets with engagement (last 30 days) | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 31.15% | Percentage of tweets with engagement (last 30 days) 97.22% | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) N/A | Percentage of tweets with engagement (last 30 days) 96% | Percentage of tweets with engagement (last 30 days) N/A |
Alexa Website Rank | Alexa Website Rank 394176 | Alexa Website Rank 326491 | Alexa Website Rank 226631 | Alexa Website Rank N/A | Alexa Website Rank 95762 | Alexa Website Rank 187498 | Alexa Website Rank 593534 |
Employee Rating | Employee Rating 3.6 | Employee Rating 3.6 | Employee Rating N/A | Employee Rating 3.7 | Employee Rating 4 | Employee Rating 4.2 | Employee Rating N/A |
Financial | |||||||
Revenue (est.) | Revenue (est.) ¥442.5b (FY, 2020) | Revenue (est.) $2.8b (FY, 2021) | Revenue (est.) $645.9b (FY, 2020) | Revenue (est.) ¥629.4b (FY, 2021) | Revenue (est.) ¥3.2t (FY, 2021) | Revenue (est.) ¥1.3t (FY, 2022) | Revenue (est.) ¥167.8b (FY, 2021) |
Cost of goods | Cost of goods ¥308.3b (FY, 2020) | Cost of goods $1.7b (FY, 2021) | Cost of goods ($133.8b) (FY, 2020) | Cost of goods (¥364.9b) (FY, 2021) | Cost of goods (¥434.6b) (FY, 2021) | Cost of goods (¥173.3b) (FY, 2022) | Cost of goods (¥111.1b) (FY, 2021) |
Gross profit | Gross profit ¥134.2b (FY, 2020) | Gross profit $1.2b (FY, 2021) | Gross profit $513.6b (FY, 2020) | Gross profit ¥264.4b (FY, 2021) | Gross profit ¥2.8t (FY, 2021) | Gross profit ¥1.2t (FY, 2022) | Gross profit ¥57.8b (FY, 2021) |
Net income | Net income (¥11.6b) (FY, 2020) | Net income $661.8m (FY, 2021) | Net income $42.5b (FY, 2020) | Net income ¥38.4b (FY, 2021) | Net income ¥376.2b (FY, 2021) | Net income ¥124.1b (FY, 2022) | Net income ¥373m (FY, 2021) |
Operating ⚠ | |||||||
Filed Trials Products (Oncology) | Filed Trials Products (Oncology) N/A | Filed Trials Products (Oncology) N/A | Filed Trials Products (Oncology) 2 (Jul, 2018) | Filed Trials Products (Oncology) N/A | Filed Trials Products (Oncology) 8 (Oct, 2020) | Filed Trials Products (Oncology) N/A | Filed Trials Products (Oncology) N/A |
Phase I Trials Products (Oncology) | Phase I Trials Products (Oncology) N/A | Phase I Trials Products (Oncology) N/A | Phase I Trials Products (Oncology) 11 (Jul, 2019) | Phase I Trials Products (Oncology) N/A | Phase I Trials Products (Oncology) 1 (Jul, 2019) | Phase I Trials Products (Oncology) 1 (FY, 2020) | Phase I Trials Products (Oncology) N/A |
Phase I/II Trials Products (Oncology) | Phase I/II Trials Products (Oncology) N/A | Phase I/II Trials Products (Oncology) N/A | Phase I/II Trials Products (Oncology) 6 (Jul, 2019) | Phase I/II Trials Products (Oncology) N/A | Phase I/II Trials Products (Oncology) 3 (Oct, 2020) | Phase I/II Trials Products (Oncology) N/A | Phase I/II Trials Products (Oncology) N/A |
Phase II Trials Products (Oncology) | Phase II Trials Products (Oncology) N/A | Phase II Trials Products (Oncology) N/A | Phase II Trials Products (Oncology) 9 (Jul, 2019) | Phase II Trials Products (Oncology) N/A | Phase II Trials Products (Oncology) 8 (Oct, 2019) | Phase II Trials Products (Oncology) 1 (FY, 2020) | Phase II Trials Products (Oncology) N/A |
Phase III Trials Products (Oncology) | Phase III Trials Products (Oncology) N/A | Phase III Trials Products (Oncology) N/A | Phase III Trials Products (Oncology) 10 (Jul, 2019) | Phase III Trials Products (Oncology) N/A | Phase III Trials Products (Oncology) 5 (Oct, 2020) | Phase III Trials Products (Oncology) 4 (Oct, 2020) | Phase III Trials Products (Oncology) N/A |
For sources of this data, please see the company profile
View company profiles
West Pharmaceutical Services
HQ
Exton, US
Employees
10,065↑ 9% increase
West Pharmaceutical Services is a company that manufactures and sells packaging components and delivery systems for injectable drugs and healthcare products internationally.
View companyEisai
HQ
Bunkyo City, JP
Employees
11,322↑ 1% increase
Eisai is a research-based human health care company that discovers, develops, packages, and markets pharmaceutical products.
View companyKuraray
HQ
Chiyoda City, JP
Employees
11,115↑ 22% increase
Kuraray is a company that manufactures chemicals, synthetic and chemical fibers, and other materials.
View company
Takeda Pharmaceutical
HQ
Tokyo, JP
Employees
47,099↓ 1% decrease
Takeda Pharmaceutical is a biopharmaceutical company.
View company